[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
IJRR Information::
For Authors::
For Reviewers::
News & Events::
Web Mail::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
Hard Copy 2322-3243
Online 2345-4229
Online Submission
Now you can send your articles to IJRR office using the article submission system.



:: Volume 15, Issue 3 (7-2017) ::
Int J Radiat Res 2017, 15(3): 267-273 Back to browse issues page
Standardization of whole breast radiotherapy is required for safe omission of axillary lymph node dissection in breast cancer patients
M. Kong , D.O. Shin
Department of Radiation Oncology, Kyung Hee University Medical Center, Kyung Hee University School of Medicine, Seoul, Republic of Korea , kongmoonkyoo@khu.ac.kr
Abstract:   (4636 Views)
Background: The purpose of this study was to assess the dose distribution and coverage of level Ⅰ-Ⅱ axillary lymph nodes during whole breast tangential field radiotherapy (RT) after breast-conserving surgery in patients with breast cancer. Materials and Methods: The level Ⅰ-Ⅱ axillary lymph node volumes were retrospectively contoured by a single radiation oncologist based on computed tomography simulation data from 44 patients who underwent breast-conserving surgery without axillary dissection and who received postoperative whole breast RT between January and December 2014. The dose distributions of the whole breast tangential RT fields were reassessed in relation to the axillary level Ⅰ and Ⅱ lymph node volumes. Results: : The average doses delivered to level I and I axillary lymph nodes were 49.4% (range, 14.2–94.6) and 30.8% (range, 2.6–71.5) of the prescribed radiation dose, respectively. The volumes receiving at least 95% of the prescribed radiation dose were 12.7% (range, 0–67.4%) for level I and 1.4% (range, 0–7.7%) for level II nodes. Compared to thin patients, the average doses delivered to axillary lymph node levels I and II were significantly higher in overweight patients. Conclusion: The radiation dose coverage of axillary lymph nodes by whole breast tangential RT varies greatly among patients. To safely omit axillary lymph node dissection from the treatment of clinically axillary lymph node negative T1-2 breast cancer patients with 1–2 positive sentinel lymph nodes, standardization and individualization of whole breast RT are necessary.

Keywords: Breast, carcinoma, lymph nodes, radiotherapy.
Full-Text [PDF 554 kb]   (1105 Downloads)    
Type of Study: Original Research | Subject: Radiation Biology
Send email to the article author

Add your comments about this article
Your username or Email:


XML     Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Kong M, Shin D. Standardization of whole breast radiotherapy is required for safe omission of axillary lymph node dissection in breast cancer patients. Int J Radiat Res 2017; 15 (3) :267-273
URL: http://ijrr.com/article-1-2057-en.html

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 15, Issue 3 (7-2017) Back to browse issues page
International Journal of Radiation Research
Persian site map - English site map - Created in 0.05 seconds with 50 queries by YEKTAWEB 4645